bioscience. questions. answered.

In US and Canada Call Toll Free: (877) 597-9236
Everywhere Else Call: (760) 431-6300

News

Affordable Benchtop Gel Documentation System

percepta

15th Jan, 2015

News

0

Clever Scientific offers an affordable gel documentation system.  The omniDOC series of gel documentation and analysis systems provide researchers with a quick, simple and flexible solution for their gel documentation needs in a compact and affordable benchtop unit.

Imaging applications are made easy by the pre-focused camera that requires little or no adjustment. The simple omniDOC ‘one-click’ image acquisition and analysis software intuitively…

read more >

Potential signs of ancient life in Mars rover photos

percepta

7th Jan, 2015

News

0

A careful study of images taken by the NASA rover Curiosity has revealed intriguing similarities between ancient sedimentary rocks on Mars and structures shaped by microbes on Earth. The findings suggest, but do not prove, that life may have existed earlier on the Red Planet.

Read more at: http://phys.org/news/2015-01-potential-ancient-life-mars-rover.html#jCp

read more >

Cause of ALS is found, Northwestern team says

percepta

7th Jan, 2015

News

0

Researchers at Northwestern University say they have discovered a common cause behind the mysterious and deadly affliction of amyotrophic lateral sclerosis, or Lou Gehrig’s disease, that could open the door to an effective treatment.  Read More…

 

read more >

Percepta Associates Inc Receives 2014 Best of Carlsbad Award

percepta

30th Sep, 2014

News

0

Carlsbad Award Program Honors the Achievement
CARLSBAD September 23, 2014 — Percepta Associates Inc has been selected for the 2014 Best of Carlsbad Award in the Market Researcher category by the Carlsbad Award Program.
Each year, the Carlsbad Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies…

read more >

NIH Government Funding for 2014 Restored…Mostly

Mason Brooks

3rd Mar, 2014

Blog, News

0

On February 10th, 2014 the National Institutes of Health (NIH) released details about its fiscal mandates for the year. President Obama signed the Consolidated Appropriations Act (Public Law 113-76) into law on January 17th 2014, ensuring funding to NIH for the fiscal year ending September 30th, 2014.

The Act provides NIH with a budget of $30.15 billion, which is an increase…

read more >

RNA Expression Profiles Fuel New Tuberculosis Diagnostic

Mason Brooks

25th Oct, 2013

Articles, Blog, News

0

In places where controlling tuberculosis (TB) is a concern, there is an urgent need for simple, inexpensive diagnostics that can identify active TB, particularly in the context of HIV infection. In a recent paper (PLoS Medicine, October 22, 2013), researchers discovered that a unique RNA transcriptional signature found in whole blood could distinguish TB from other diseases including HIV…

read more >

Luciferase Assays Drive Revenue Generation in Reporter Gene Assays Market

percepta

30th Aug, 2013

News

0

With an Expected Decline to Low Single Digit Growth across Various Reporter Gene Assay Segments, Luciferase Assay Demand Remains Strong
Carlsbad, Calif. – August 30, 2013: Percepta Associates announces the launch of its Reporter Gene Assays Life Science Dashboard™ market research report revealing Life Technologies (including Invitrogen brand), Promega, Sigma Aldrich, Clontech, Thermo Fisher (including Pierce brand), Roche Applied Sciences…

read more >

Percepta Nucleic Acid Purification (China) Dashboard Featured in GEN

percepta

17th Jul, 2013

News

0

Carlsbad, Calif. – Just a fraction of the many insights uncovered in Percepta’s 2013 Series One Nucleic Acid Purification (China) Life Science Dashboard™ was featured in the latest issue of Genetic Engineering and Biotechnology News. You can see the article here: GEN (Jul 1, 2013 (Vol. 33, No. 13)) .  To learn more about obtaining a complete version of…

read more >

Percepta Survey Finds Personnel, Reagent and Instrument Spending in Academic Research Labs Negatively Affected Both Prior to and Post Budget Sequester

percepta

15th Apr, 2013

News

0

CARLSBAD, CALIFORNIA – Though the U.S. Federal government implemented budget sequestration on March 1st, canceling $85 billion in budgetary resources across the Federal government for the remainder of the 2013 fiscal year, U.S. academic researchers spend on life science reagents and instruments decreased as early as October, 2012, according to Percepta’s recent benchmarking study.

The study objectives were to understand…

read more >

Growing at an Attractive Rate, the Fluorescent Imaging Research Market Presents Promising Opportunities for New Product Development

percepta

11th Mar, 2013

News

4

Life Technologies Dominates the Market, while Abcam and BD Biosciences Maintain a Strong Presence.
Carlsbad, Calif. – March 11, 2013: Percepta Associates announces the launch of its Fluorescent Imaging Life Science Dashboard™ market research report revealing Life Technologies (including Molecular Probes and Invitrogen brands), Abcam and BD Biosciences as leading suppliers across various segments.  Market segments analyzed in this report…

read more >

Copyright © 2019 Percepta Associates Inc. All rights reserved. Terms & Conditions.Designed by Audacity